Shares of Targanta Therapeutics Surge on Positive FDA Review

Shares of biotechnology company Targanta Therapeutics Inc. surged Monday after federal regulators posted a favorable review of the company's antibiotic, ahead of a meeting to assess the prodcut later this week.
MORE ON THIS TOPIC